Stock Split History
ETFs Holding INO »    INO Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Inovio Pharmaceuticals is a biotechnology company focused on bringing the designed deoxyribonucleic acid (DNA) medicines and vaccines to help protect people from infectious diseases, including COVID-19, and to help treat people with cancer, and conditions associated with human papillomavirus. Co.'s DNA medicines pipeline is comprised of three types of product candidates: prophylactic DNA vaccines, therapeutic DNA immunotherapies, and DNA encoded monoclonal and bispecific antibodies, all of which utilize the two components of Co.'s integrated platform, SynCon® and CELLECTRA®. Co. is evaluating the feasibility of, conducting or planning clinical studies of its DNA medicines. According to our Inovio Pharmaceuticals stock split history records, Inovio Pharmaceuticals has had 1 split.
Inovio Pharmaceuticals stock split history picture
Inovio Pharmaceuticals (INO) has 1 split in our Inovio Pharmaceuticals stock split history database. The split for INO took place on June 06, 2014. This was a 1 for 4 reverse split, meaning for each 4 shares of INO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 250 share position following the split.

When a company such as Inovio Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the Inovio Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 250 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Inovio Pharmaceuticals shares, starting with a $10,000 purchase of INO, presented on a split-history-adjusted basis factoring in the complete Inovio Pharmaceuticals stock split history. Inovio Pharmaceuticals split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 09/26/2012
End date: 09/23/2022
Start price/share: $2.36
End price/share: $1.71
Dividends collected/share: $0.00
Total return: -27.54%
Average Annual Total Return: -3.17%
Starting investment: $10,000.00
Ending investment: $7,246.66
Years: 10.00
Date Ratio
06/06/20141 for 4
INO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

INSY Split History
INVA Split History
IPCI Split History
IRWD Split History
ISRG Split History
ITUS Split History
IVC Split History
JAGX Split History
JNJ Split History
JUNO Split History

Also explore: INO shares outstanding history

Email EnvelopeFree INO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
TD Holdings, Inc. (GLG )
Iterum Therapeutics plc (ITRM)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Inovio Pharmaceuticals
Inovio Pharmaceuticals Insider Buying

Inovio Pharmaceuticals Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.